Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to determine the safety and efficacy of IP-001 for
intratumoral injection administration following thermal ablation of a solid tumor.